# Controlled Study of ONO-8025 (KRP-197) in Patients With Overactive Bladder in Japan

> **NCT00212732** · PHASE3 · COMPLETED · sponsor: **Ono Pharmaceutical Co., Ltd.** · enrollment: 750 (—)

## Conditions studied

- Overactive Bladder

## Interventions

- **DRUG:** ONO-8025 (KRP-197)

## Key facts

- **NCT ID:** NCT00212732
- **Lead sponsor:** Ono Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-10
- **Primary completion:** 2006-04
- **Final completion:** —
- **Target enrollment:** 750 (—)
- **Last updated:** 2012-10-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00212732

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00212732, "Controlled Study of ONO-8025 (KRP-197) in Patients With Overactive Bladder in Japan". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00212732. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*